Technical Analysis for RLYB - Rallybio Corporaton
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Oversold Stochastic | Weakness | 0.00% | |
| NR7 | Range Contraction | 3.51% | |
| NR7-2 | Range Contraction | 3.51% | |
| Narrow Range Bar | Range Contraction | 3.51% | |
| Oversold Stochastic | Weakness | 3.51% | |
| MACD Bearish Signal Line Cross | Bearish | 3.51% | |
| New 52 Week Closing Low | Bearish | 3.51% | |
| NR7 | Range Contraction | 3.51% | |
| Narrow Range Bar | Range Contraction | 3.51% | |
| Stochastic Reached Oversold | Weakness | 3.51% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 21 hours ago |
| Up 3% | about 21 hours ago |
| Up 2% | about 21 hours ago |
| Up 1% | about 21 hours ago |
| Possible NR7 | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
Rallybio is a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases. Since its launch in January 2018, Rallybio has built a portfolio of promising product candidates, which are now in development to address rare diseases in the areas of hematology, immuno-inflammation, maternal fetal health and metabolic disorders. The Company’s mission is being advanced by a team of highly experienced biopharma industry leaders with extensive research, development, and rare disease expertise. Rallybio is headquartered in New Haven, Connecticut, with an additional facility at the University of Connecticut’s Technology Incubation Program in Farmington, Connecticut.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Rare Diseases Metabolic Disorders Severe And Rare Diseases Greater Hartford
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Rare Diseases Metabolic Disorders Severe And Rare Diseases Greater Hartford
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.46 |
| 52 Week Low | 0.95 |
| Average Volume | 67,331 |
| 200-Day Moving Average | 1.44 |
| 50-Day Moving Average | 1.07 |
| 20-Day Moving Average | 1.02 |
| 10-Day Moving Average | 1.02 |
| Average True Range | 0.06 |
| RSI (14) | 43.82 |
| ADX | 23.21 |
| +DI | 18.03 |
| -DI | 18.55 |
| Chandelier Exit (Long, 3 ATRs) | 0.98 |
| Chandelier Exit (Short, 3 ATRs) | 1.12 |
| Upper Bollinger Bands | 1.09 |
| Lower Bollinger Band | 0.95 |
| Percent B (%b) | 0.34 |
| BandWidth | 14.06 |
| MACD Line | -0.02 |
| MACD Signal Line | -0.02 |
| MACD Histogram | -0.0028 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.07 | ||||
| Resistance 3 (R3) | 1.07 | 1.04 | 1.06 | ||
| Resistance 2 (R2) | 1.04 | 1.02 | 1.04 | 1.05 | |
| Resistance 1 (R1) | 1.02 | 1.01 | 1.03 | 1.02 | 1.05 |
| Pivot Point | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 |
| Support 1 (S1) | 0.97 | 0.97 | 0.98 | 0.97 | 0.94 |
| Support 2 (S2) | 0.94 | 0.96 | 0.94 | 0.94 | |
| Support 3 (S3) | 0.92 | 0.94 | 0.93 | ||
| Support 4 (S4) | 0.92 |
